The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

The Value of Next-Generation Sequencing for Treatment in Non-Small Cell Lung Cancer Patients: The Observational, Real-World Evidence in China

Background. Great success has been made in the targeting therapy of advanced non-small cell lung cancer (NSCLC). Nowadays, next generation sequencing (NGS) is acquirable and affordable in developed area of China. Using this feasible and accurate method of detecting therapeutic genes would help to se...

Full description

Bibliographic Details
Main Authors: Yan Zhang, Wen-Xiang Shen, Li-Na Zhou, Min Tang, Yue Tan, Chun-Xia Feng, Ping Li, Li-Qiang Wang, Min-Bin Chen
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2020/9387167

Internet

http://dx.doi.org/10.1155/2020/9387167

Similar Items